Effective Pharmaceuticals

Effective Pharmaceuticals is a private biotechnology company focused on the discovery and development of novel therapeutic agents for oncology, cardiovascular, and inflammatory diseases. Founded by Dr. Shaker Mousa, the company specializes in the application of nanotechnology and medicinal chemistry to create targeted therapies, with a particular emphasis on integrin receptor antagonists. Its research efforts are closely aligned with the Pharmaceutical Research Institute (PRI), aiming to translate complex molecular biology into effective clinical treatments. The company's pipeline primarily consists of early-stage candidates designed to modulate angiogenesis and tumor microenvironments through highly specific molecular targeting.